Thanks to the generosity of the type 1 diabetes community, we have completed recruitment for the BANDIT clinical trial, Australia’s first immunotherapy trial for type 1 diabetes.

St Vincent’s Institute of Medical Research (SVI), which is leading the trial, hopes to begin sharing information about the trial findings in 2023. Visit the SVI website for more details.

Are you interested in participating in a clinical trial?

The IMPACT trial is now recruiting participants.

We’re looking for people aged 18 to 45 years who have recently been diagnosed with type 1 diabetes.

For more information about IMPACT, click here.